Anti-KCC2 Antibody [N1/12 (Formerly sold as S1-12)]

(No reviews yet) Write a Review
SKU:
STMA00107
Antibody Type:
Monoclonal
Applications:
WB
Applications:
IHC
Applications:
ICC/IF
Applications:
IP
Reactivity:
Human
Reactivity:
Mouse
Reactivity:
Rat
Host Species:
Mouse
Isotype:
IgG2a
  • Immunocytochemistry/Immunofluorescence analysis using Mouse Anti-KCC2 Monoclonal Antibody, Clone N1/12 (STMA00107). Tissue: Neuroblastoma cells (SH-SY5Y). Species: Human. Fixation: 4% PFA for 15 min. Primary Antibody: Mouse Anti-KCC2 Monoclonal Antibody (STMA00107) at 1:200 for overnight at 4°C with slow rocking. Secondary Antibody: AlexaFluor 488 at 1:1000 for 1 hour at RT.
  • Immunocytochemistry/Immunofluorescence analysis using Mouse Anti-KCC2 Monoclonal Antibody, Clone N1/12 (STMA00107). Tissue: Neuroblastoma cell line (SK-N-BE). Species: Human. Fixation: 4% Formaldehyde for 15 min at RT. Primary Antibody: Mouse Anti-KCC2 Monoclonal Antibody (STMA00107) at 1:100 for 60 min at RT. Secondary Antibody: Goat Anti-Mouse ATTO 488 at 1:200 for 60 min at RT.
  • Western Blot analysis of Rat brain membrane lysate showing detection of KCC2 protein using Mouse Anti-KCC2 Monoclonal Antibody, Clone N1/12 (STMA00107). Primary Antibody: Mouse Anti-KCC2 Monoclonal Antibody (STMA00107) at 1:1000.
Frequently bought together:

Description

KCC2 Antibody [N1/12 (Formerly sold as S1-12)]

KCC2 Antibody [N1/12 (Formerly sold as S1-12)] is a mouse monoclonal antibody directed against KCC2, offered by Assay Genie for research applications. Reported applications include WB, IHC, ICC/IF and IP. Reported reactivity: Human, Mouse and Rat. Supplied as IgG2a, purified by Protein G.

KCC2 (potassium-chloride cotransporter 2) is a neuron-specific member of the cation-chloride cotransporter family, essential for maintaining low intracellular chloride concentrations. By leveraging potassium gradients, KCC2 facilitates chloride extrusion, enabling hyperpolarizing GABAergic inhibition—a cornerstone of neuronal stability and synaptic precision. Highly expressed throughout the central nervous system, KCC2 is enriched at inhibitory synapses, particularly in the spinal cord and brain. Its function is critical for establishing the inhibitory tone required for proper motor control, sensory processing, and cognitive function. Disruption of KCC2 activity alters chloride homeostasis, leading to depolarizing GABA responses and impaired inhibitory signaling. Animal studies have demonstrated that KCC2 deficiency results in severe neurological phenotypes, including motor dysfunction, epilepsy, and anxiety-like behaviors. These findings underscore KCC2’s pivotal role in maintaining excitatory-inhibitory balance and highlight its relevance in the pathogenesis of neurodegenerative and neurodevelopmental disorders. In conditions such as Alzheimer’s disease, amyotrophic lateral sclerosis (ALS), and traumatic brain injury, KCC2 downregulation contributes to neuronal hyperexcitability and excitotoxicity. As a result, KCC2 has emerged as a promising therapeutic target. Pharmacological and genetic strategies aimed at enhancing KCC2 function are being actively explored to restore inhibitory signaling and protect against neurodegeneration. KCC2’s central role in chloride regulation, synaptic inhibition, and disease progression positions it as a key focus in neuroscience and neurotherapeutic research. This antibody is also available conjugated to ATTO 390, ATTO 488, ATTO 594, APC, Biotin, FITC, HRP, PerCP and RPE. Supplied in 100 µg. For research use only; not for diagnostic or therapeutic procedures.

View AllClose

0 Reviews

View AllClose